These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1804032)

  • 21. Botulinum toxin and dystonias.
    Drug Ther Bull; 1991 Dec; 29(26):102-3. PubMed ID: 1790760
    [No Abstract]   [Full Text] [Related]  

  • 22. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients].
    Ceballos-Baumann AO; Gasser T; Dengler R; Oertel WH
    Nervenarzt; 1990 Oct; 61(10):604-10. PubMed ID: 2274092
    [No Abstract]   [Full Text] [Related]  

  • 25. Botulinum toxin in cervical dystonia.
    Tsui JK; Calne DB
    Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H
    J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A.
    Greene PE; Fahn S
    Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
    Novis SA; De Mattos JP; De Rosso AL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of dystonic blepharospasm and hemifacial spasm with botulinum toxin: preliminary studies].
    Martí MJ; Kulisevsky J; Tolosa E
    Med Clin (Barc); 1987 Sep; 89(8):321-3. PubMed ID: 3320608
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of botulinum toxin in the treatment of cervical dystonia.
    Poewe W; Wissel J
    Baillieres Clin Neurol; 1993 Apr; 2(1):179-85. PubMed ID: 8143072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin treatment in clinical neurology.
    Van den Bergh P
    Acta Neurol Belg; 1995; 95(2):70-9. PubMed ID: 7618431
    [No Abstract]   [Full Text] [Related]  

  • 32. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin A in clinical medicine.
    Elston JS
    J Physiol (Paris); 1990; 84(4):285-9. PubMed ID: 2079665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.
    Lees AJ; Turjanski N; Rivest J; Whurr R; Lorch M; Brookes G
    J Neurol; 1992 Jan; 239(1):1-4. PubMed ID: 1541963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulin in the treatment of local dystonia].
    Domzał T
    Neurol Neurochir Pol; 1992; 26(6):783-9. PubMed ID: 1301505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990.
    Arch Neurol; 1991 Dec; 48(12):1294-8. PubMed ID: 1845036
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.